financetom
Business
financetom
/
Business
/
CSX names Steve Angel as new CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CSX names Steve Angel as new CEO
Sep 29, 2025 5:39 AM

Sept 29 (Reuters) - CSX Corp ( CSX ) said on Monday that

it has named Steve Angel as its CEO, effective Sept. 28.

(Reporting by Nathan Gomes in Bengaluru; Editing by Mrigank

Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canada could slap tariffs on C$150 billion worth of US imports, source says
Canada could slap tariffs on C$150 billion worth of US imports, source says
Jan 15, 2025
OTTAWA (Reuters) - Canada could impose countermeasures on up to C$150 billion worth of U.S. imports if President-elect Donald Trump puts tariffs on Canadian goods and services, a source familiar with the matter said on Wednesday. Canada has drawn up a list of targets but would hold public consultations before acting, said the source, adding the extent of any potential...
Ackman's Pershing Square requests UMG to move secondary listing to US
Ackman's Pershing Square requests UMG to move secondary listing to US
Jan 15, 2025
(Reuters) - Universal Music Group said on Wednesday that billionaire Bill Ackman-led Pershing Square has exercised its right to request an offering and secondary listing of the record label in the United States. In November, Ackman said he would seek to relocate both his own investment firm Pershing Square and UMG - whose roster of stars includes Taylor Swift -...
Novartis loses emergency bid to block Entresto generic in US
Novartis loses emergency bid to block Entresto generic in US
Jan 15, 2025
WASHINGTON - A Washington, D.C. federal judge on Wednesday refused Novartis' eleventh-hour bid to block drugmaker MSN Pharmaceuticals from launching a generic version of Novartis' blockbuster heart-failure drug Entresto. The decision by U.S. District Judge Dabney Friedrich clears a hurdle for MSN to introduce the first U.S. generic version of Switzerland-based Novartis' best-selling drug, which brought the company more than...
Novartis loses emergency bid to block Entresto generic in US
Novartis loses emergency bid to block Entresto generic in US
Jan 15, 2025
WASHINGTON, Jan 15 - A Washington, D.C. federal judge on Wednesday refused Novartis' eleventh-hour bid to block drugmaker MSN Pharmaceuticals from launching a generic version of Novartis' blockbuster heart-failure drug Entresto. The decision by U.S. District Judge Dabney Friedrich clears a hurdle for MSN to introduce the first U.S. generic version of Switzerland-based Novartis' best-selling drug, which brought the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved